January 16, 2020
Fortress Biotech's partner Cyprium Therapeutics’ has received Rare Pediatric Disease Designation from the FDA for its Menkes treatment.
July 4, 2019
We're halfway through the year, which means it's time to reflect on the top performing NASDAQ pharma stocks year-to-date.
April 3, 2019
The first quarter of the year is over, which means it's time to reflect on the top performing pharma stocks...
February 12, 2019
Fortress Biotech (NASDAQ: FBIO) has announced it completed the second and final stage of the previously-announced sale of its remaining holdings of...
February 10, 2019
Melinta Therapeutics, BioXcel Therapeutics, Eyenovia, Forward Pharma and Trevena were last week's top gainers.
September 7, 2018
Checkpoint Therapeutics released preliminary results for its clinical trial on Thursday, but investors are not sharing the enthusiasm.